Be the cure
Be the cure
Be the
Change a life
Change a life
Change a
Join our team
Join our team
Join our

The expertise to create cures and life-changing treatments

Assembly Bio is passionately applying scientific ingenuity, and a deep knowledge of virology to find a cure for hepatitis B (HBV), one of the world’s most prevalent and devastating infectious diseases. At the same time, we are advancing a microbiome portfolio of live biotherapeutics capable of transforming lives in a broad range of tough-to-treat conditions. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives.

rotating circle rotating circle rotating circle
Explore more >
rotating circlerotating circle rotating circle
Discover more >
In the News
July 09, 2020
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection
July 02, 2020
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 25, 2020
Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection
    Tech in lab

    It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.”

    — Alan Wang, Emmy award-winning television news anchor.
    Infected at birth with chronic Hepatitis B.